Team:BIOTEC Dresden/Notebook2-4

From 2009.igem.org

Revision as of 12:28, 21 October 2009 by Stanley (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Contact

Acknowledgments

Photos

Meetings

Team

Home

[http://partsregistry.org/cgi/partsdb/pgroup.cgi?pgroup=iGEM2009&group=BIOTEC_Dresden Biobricks]

Outreach

Safety

21st September’09:

1. A silver Binding Peptide Assay has been carried out along with the Bradford Assay.

22th September’09:

1. Minipreps pFRT-DhfR has been done.

2. Miniprep DNA concentrations for of pF3-ZeoR-F3-RFP and TT-FRT-GFP-BsdR has been measured.

3. A test for Blasticidin resistance has been carried out for TT-FRT-GFP-BsdR containing plasmids.

4. A test for Trimethoprin resistance has been carried out for pMA-FRT-DhfR (500bp, 1000bp, 2000bp, 5000bp, 10,000bp) containing plasmids and also for GB2005Red and Fos2-SpectR.

23rd September’09:

1. Minipreps of pRhaFlp has been done followed by a restriction digest with NheI.

2. A restriction digest of pF3-ZeoR-F3-RFP has been done with PvuII.

3. Reinoculation of pTetFlp-KanR has been done.

24th September’09:

1. The restriction digest of pF3-ZeoR-F3-RFP is run on a gel to gel purify the insert.

2. A midiprep for pTetFlp-KanR is done and the concentrations are measured.

25th September’09:

1. The miniprep concentrations of pF3-ZeoR-F3-RFP and TT-FRT-GFP-BsdR have been measured.

2. The previous colonies are sub-cultured in liquid broth and also for the pRhaFlp-CmR-KanR in LB-Cm10-Kan15 and Trimethoprin plates.